Biotech Values

[DewDiligence]

>I like MNTA as a "story stock" but haven't done much DD as to whether they are worth investing in.<

The problem is that, since the Lovenox patent case went against SNY, MNTA’s valuation has been exceedingly high for a “story stock.” I doubt I would buy into their story unless the valuation returned to level commensurate with a company that has yet to prove its claims.